JP2004528312A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004528312A5 JP2004528312A5 JP2002576207A JP2002576207A JP2004528312A5 JP 2004528312 A5 JP2004528312 A5 JP 2004528312A5 JP 2002576207 A JP2002576207 A JP 2002576207A JP 2002576207 A JP2002576207 A JP 2002576207A JP 2004528312 A5 JP2004528312 A5 JP 2004528312A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- phenyl
- substituted
- hydrogen
- och
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 21
- 229910052739 hydrogen Inorganic materials 0.000 claims 14
- 239000001257 hydrogen Substances 0.000 claims 14
- 150000001875 compounds Chemical class 0.000 claims 13
- 229910052736 halogen Inorganic materials 0.000 claims 10
- 150000002367 halogens Chemical class 0.000 claims 10
- 150000003839 salts Chemical class 0.000 claims 10
- 239000012458 free base Substances 0.000 claims 9
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 8
- 239000002253 acid Substances 0.000 claims 8
- 150000002431 hydrogen Chemical class 0.000 claims 6
- 125000000171 (C1-C6) haloalkyl group Chemical group 0.000 claims 4
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 4
- BJLUORNGPCXNHM-UHFFFAOYSA-N 1h-pyrido[3,2-d]pyrimidine-2,4-dione Chemical compound C1=CN=C2C(=O)NC(=O)NC2=C1 BJLUORNGPCXNHM-UHFFFAOYSA-N 0.000 claims 4
- HYSLHVMRVBBRIG-UHFFFAOYSA-N 6-chloro-2-methyl-1h-pyrido[3,2-d]pyrimidin-4-one Chemical compound C1=C(Cl)N=C2C(=O)NC(C)=NC2=C1 HYSLHVMRVBBRIG-UHFFFAOYSA-N 0.000 claims 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 4
- 125000006277 halobenzyl group Chemical group 0.000 claims 4
- 125000004076 pyridyl group Chemical group 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 102000011040 TRPV Cation Channels Human genes 0.000 claims 2
- 108010062740 TRPV Cation Channels Proteins 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 2
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 201000005569 Gout Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 150000008043 acidic salts Chemical group 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 201000008482 osteoarthritis Diseases 0.000 claims 1
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 claims 1
- 239000008024 pharmaceutical diluent Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 201000004595 synovitis Diseases 0.000 claims 1
- 210000002435 tendon Anatomy 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0107505.0 | 2001-03-26 | ||
| GB0107505A GB0107505D0 (en) | 2001-03-26 | 2001-03-26 | Organic compounds |
| US33828101P | 2001-12-06 | 2001-12-06 | |
| US60/338,281 | 2001-12-06 | ||
| PCT/EP2002/003332 WO2002076946A2 (en) | 2001-03-26 | 2002-03-25 | Fused pyridine derivatives for use as vanilloid receptor antagonists for treating pain. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004528312A JP2004528312A (ja) | 2004-09-16 |
| JP2004528312A5 true JP2004528312A5 (enExample) | 2005-08-04 |
| JP4205430B2 JP4205430B2 (ja) | 2009-01-07 |
Family
ID=26245894
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002576207A Expired - Fee Related JP4205430B2 (ja) | 2001-03-26 | 2002-03-25 | 疼痛を治療するための、バニロイド受容体アンタゴニストとして、使用するための縮合ピリジン誘導体 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7915264B2 (enExample) |
| EP (1) | EP1377576A2 (enExample) |
| JP (1) | JP4205430B2 (enExample) |
| KR (1) | KR20030083755A (enExample) |
| CN (1) | CN1500089A (enExample) |
| BR (1) | BR0208338A (enExample) |
| CA (1) | CA2441599A1 (enExample) |
| CZ (1) | CZ20032561A3 (enExample) |
| HU (1) | HUP0303623A2 (enExample) |
| IL (1) | IL157815A0 (enExample) |
| MX (1) | MXPA03008754A (enExample) |
| NO (1) | NO326546B1 (enExample) |
| PE (1) | PE20021161A1 (enExample) |
| PL (1) | PL363907A1 (enExample) |
| RU (1) | RU2003130221A (enExample) |
| SK (1) | SK11952003A3 (enExample) |
| WO (1) | WO2002076946A2 (enExample) |
Families Citing this family (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU8022901A (en) | 2000-08-21 | 2002-03-04 | Pacific Corp | Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| JP2004506714A (ja) | 2000-08-21 | 2004-03-04 | パシフィック コーポレーション | 新規チオ尿素化合物及びこれを含有する薬学的組成物 |
| PL371587A1 (en) | 2002-01-17 | 2005-06-27 | Neurogen Corporation | Substituted quinazolin-4-ylamine analogues as modulators of capsaicin receptors |
| DK1472225T3 (da) | 2002-02-01 | 2010-08-09 | Euro Celtique Sa | 2-Piperazinpyridiner, som er anvendelige til behandling af smerte |
| US6864261B2 (en) | 2002-05-02 | 2005-03-08 | Euro-Celtique S.A. | Therapeutic agents useful for treating pain |
| GB0229808D0 (en) * | 2002-12-20 | 2003-01-29 | Glaxo Group Ltd | Novel compositions |
| ES2337254T3 (es) | 2003-02-14 | 2010-04-22 | Glaxo Group Limited | Derivados de carboxamida. |
| WO2004103954A1 (ja) | 2003-05-20 | 2004-12-02 | Ajinomoto Co., Inc. | アミド誘導体 |
| GB0319150D0 (en) | 2003-08-14 | 2003-09-17 | Glaxo Group Ltd | Novel compounds |
| AU2004290626A1 (en) | 2003-11-14 | 2005-06-02 | Merck Sharp & Dohme Limited | Bicyclic pyrimidin-4-(3H)-ones and analogues and derivatives thereof which modulate the function of the vanilloid-1 receptor (VR1) |
| GB0412769D0 (en) | 2004-06-08 | 2004-07-07 | Novartis Ag | Organic compounds |
| WO2006019965A2 (en) * | 2004-07-16 | 2006-02-23 | Takeda San Diego, Inc. | Dipeptidyl peptidase inhibitors |
| WO2006007851A2 (en) | 2004-07-19 | 2006-01-26 | Novo Nordisk A/S | Capsaicin inhibitors for treating obesity and-related disorders |
| DE102004039373A1 (de) | 2004-08-12 | 2006-02-23 | Grünenthal GmbH | Para-Alkyl-substituierte N-(4-Hydroxy-3-methoxy-benzyl)-zimtsäureamide und deren Verwendung zur Herstellung von Arzneimitteln |
| KR20060087386A (ko) | 2005-01-28 | 2006-08-02 | 주식회사 대웅제약 | 신규 벤조이미다졸 유도체 및 이를 함유하는 약제학적조성물 |
| WO2006098554A1 (en) * | 2005-03-16 | 2006-09-21 | Amorepacific Corporation | Novel compounds, isomer thereof or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and a pharmaceutical composition containing the same |
| GB0506147D0 (en) * | 2005-03-24 | 2005-05-04 | Merck Sharp & Dohme | Therapeutic agents |
| GB0509573D0 (en) * | 2005-05-11 | 2005-06-15 | Merck Sharp & Dohme | Therapeutic compounds |
| WO2006122200A1 (en) * | 2005-05-11 | 2006-11-16 | Merck Sharp & Dohme Limited | 2,3-substituted fused bicyclic pyrimidin-4(3h)-ones modulating the function of the vanilloid-1 receptor (vr1) |
| CN103382176A (zh) * | 2005-10-19 | 2013-11-06 | 格吕伦塔尔有限公司 | 新颖的辣椒素受体配体和它们用于生产药物的用途 |
| GB0525068D0 (en) | 2005-12-08 | 2006-01-18 | Novartis Ag | Organic compounds |
| KR100761222B1 (ko) * | 2006-03-08 | 2007-10-04 | 성균관대학교산학협력단 | 약물의존중독을 예방 및 치료하기 위한 바닐로이드 수용체길항제 |
| GB0614471D0 (en) | 2006-07-20 | 2006-08-30 | Syngenta Ltd | Herbicidal Compounds |
| AU2007288203B2 (en) | 2006-08-23 | 2013-01-17 | Neurogen Corporation | 2-phenoxy pyrimidinone analogues |
| US20080207659A1 (en) | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
| TW200902014A (en) * | 2007-04-20 | 2009-01-16 | Novartis Ag | Uses of vanilloid receptor antagonists |
| BRPI0813825A2 (pt) * | 2007-07-18 | 2015-01-06 | Novartis Ag | Combinações sinergísticas de antagonistas de vr-1 e inibidores da cox-2 |
| EP2229388A4 (en) * | 2008-01-11 | 2012-03-07 | Glenmark Pharmaceuticals Sa | CONDENSED PYRIMIDINE DERIVATIVES AS TRPV3 MODULATORS |
| WO2009121036A2 (en) * | 2008-03-27 | 2009-10-01 | Neurogen Corporation | Substituted aryl pyrimidinone derivatives |
| NZ587771A (en) | 2008-04-18 | 2011-05-27 | Dae Woong Pharma | Novel benzoxazine benzimidazole derivatives, pharmaceutical composition comprising same, and a use thereof |
| US8349852B2 (en) | 2009-01-13 | 2013-01-08 | Novartis Ag | Quinazolinone derivatives useful as vanilloid antagonists |
| WO2011092293A2 (en) | 2010-02-01 | 2011-08-04 | Novartis Ag | Cyclohexyl amide derivatives as crf receptor antagonists |
| CN102762572A (zh) | 2010-02-01 | 2012-10-31 | 诺瓦提斯公司 | 作为CRF-1受体拮抗剂的吡唑并[5,1b]*唑衍生物 |
| US8835444B2 (en) | 2010-02-02 | 2014-09-16 | Novartis Ag | Cyclohexyl amide derivatives as CRF receptor antagonists |
| KR101293384B1 (ko) | 2010-10-13 | 2013-08-05 | 주식회사 대웅제약 | 신규 피리딜 벤조옥사진 유도체, 이를 포함하는 약학 조성물 및 이의 용도 |
| UY34094A (es) | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
| EA201491990A1 (ru) | 2012-05-03 | 2015-02-27 | Новартис Аг | L-малатная соль 2,7-диазаспиро[4.5]дец-7-иловых производных и их кристаллические формы в качестве агонистов грелиновых рецепторов |
| ES2991706T3 (es) | 2015-12-23 | 2024-12-04 | Commw Scient Ind Res Org | Compuestos de enamina para protección contra radiación UV |
| CN108863949B (zh) * | 2018-07-09 | 2021-01-15 | 湖南博隽生物医药有限公司 | 一种用于治疗慢性炎性痛的辣椒素受体拮抗剂及合成方法 |
| DE102022104759A1 (de) | 2022-02-28 | 2023-08-31 | SCi Kontor GmbH | Co-Kristall-Screening Verfahren, insbesondere zur Herstellung von Co-Kristallen |
| CN114605408B (zh) * | 2022-03-30 | 2023-06-16 | 沈阳药科大学 | 5-羟基-1,3-二取代苯基吡啶并[2,3-d]嘧啶类化合物及其制法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2749344A (en) | 1953-01-02 | 1956-06-05 | Burroughs Wellcome Co | Pyrimidine compounds |
| US5958930A (en) * | 1991-04-08 | 1999-09-28 | Duquesne University Of The Holy Ghost | Pyrrolo pyrimidine and furo pyrimidine derivatives |
| EP0743855A1 (en) | 1994-01-03 | 1996-11-27 | Acea Pharmaceuticals, Inc. | 8-aza, 6-aza and 6,8-diaza-1,4-dihydroquinoxaline-2,3-diones and the use thereof as antagonists for the glycine/nmda receptor |
| FR2750862B1 (fr) | 1996-07-12 | 1998-10-16 | Dupin Jean Pierre | Utilisation d'heterocycles diazotes fusionnes avec un systeme aromatique ou heteroaromatique pour le traitement des maladies thrombo-emboliques |
-
2002
- 2002-03-25 IL IL15781502A patent/IL157815A0/xx unknown
- 2002-03-25 KR KR10-2003-7012460A patent/KR20030083755A/ko not_active Ceased
- 2002-03-25 WO PCT/EP2002/003332 patent/WO2002076946A2/en not_active Ceased
- 2002-03-25 JP JP2002576207A patent/JP4205430B2/ja not_active Expired - Fee Related
- 2002-03-25 HU HU0303623A patent/HUP0303623A2/hu unknown
- 2002-03-25 US US10/469,756 patent/US7915264B2/en not_active Expired - Fee Related
- 2002-03-25 RU RU2003130221/04A patent/RU2003130221A/ru not_active Application Discontinuation
- 2002-03-25 EP EP02730062A patent/EP1377576A2/en not_active Withdrawn
- 2002-03-25 CA CA002441599A patent/CA2441599A1/en not_active Abandoned
- 2002-03-25 BR BR0208338-8A patent/BR0208338A/pt not_active IP Right Cessation
- 2002-03-25 CZ CZ20032561A patent/CZ20032561A3/cs unknown
- 2002-03-25 CN CNA028073495A patent/CN1500089A/zh active Pending
- 2002-03-25 SK SK1195-2003A patent/SK11952003A3/sk unknown
- 2002-03-25 PL PL02363907A patent/PL363907A1/xx not_active Application Discontinuation
- 2002-03-25 MX MXPA03008754A patent/MXPA03008754A/es not_active Application Discontinuation
- 2002-03-26 PE PE2002000241A patent/PE20021161A1/es not_active Application Discontinuation
-
2003
- 2003-09-16 NO NO20034122A patent/NO326546B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004528312A5 (enExample) | ||
| CA2748864C (en) | Amino-heterocyclic compounds used as pde9 inhibitors | |
| US8507504B2 (en) | Process for producing bicycloaniline derivatives | |
| US9422300B2 (en) | Bisulfate of janus kinase (JAK) inhibitor and preparation method therefor | |
| RU2003130221A (ru) | Сконденсированные пиридиновые производные, предназначенные для применения в качестве антагонистов ваниллоидного рецептора при лечении боли | |
| CN114174303B (zh) | 作为sting激动剂的大环化合物及其方法和用途 | |
| PL167097B1 (pl) | Sposób wytwarzania nowych enancjomerycznych analogów nukleozydów purynowych PL PL | |
| JP2008513498A5 (enExample) | ||
| JP2005526691A5 (enExample) | ||
| WO2000012497B1 (en) | Quinazoline derivatives as medicaments | |
| KR102598246B1 (ko) | Jak 저해제로서 헤테로사이클릭 화합물, 및 이의 염 및 치료학적 용도 | |
| JP5654467B2 (ja) | ４−アミノ−３−（イミダゾリル）−ピラゾロ［３，４−ｄ］ピリミジン | |
| RU2002104935A (ru) | ПРОИЗВОДНЫЕ 8-ФЕНИЛ-6,9-ДИГИДРО[1,2,4]ТРИАЗОЛО[3,4-i]ПУРИН-5-ОНА | |
| JP2001510843A5 (enExample) | ||
| CA2671470A1 (en) | Powder formulation for valganciclovir | |
| EP2247601A1 (en) | Thiazopyrimidinones and uses thereof | |
| CN115066425B (zh) | Jak抑制剂在制备治疗jak激酶相关疾病药物中的应用 | |
| ES2488821T3 (es) | Proceso de preparación de un compuesto antiviral | |
| JP7597710B2 (ja) | 置換インドール二量体の化合物 | |
| JP2004536079A5 (enExample) | ||
| US10358447B2 (en) | Substituted 2-N-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same | |
| CA2433409A1 (en) | Use of mglur5 antagonists for the treatment of pruritic conditions | |
| JP2004517947A5 (enExample) | ||
| US12018024B2 (en) | Compounds and compositions for the treatment of cryptosporidiosis | |
| JP2007516296A5 (enExample) |